A Study of Breast Cancer Risk Factors and Outcomes of People in Florida
NCT ID: NCT06780176
Last Updated: 2025-08-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
750 participants
OBSERVATIONAL
2025-01-13
2030-01-13
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Factors Associated With Breast Cancer Risks and Outcomes
NCT07294703
Biomarkers for Breast Cancer Risk in African American Women
NCT01736306
Phase II Study of Systemic Screening in Pathologic Node Positive Breast Cancer
NCT06833502
Multiplex Testing for Breast Cancer Susceptibility: A Pilot Study of Subject Preferences for Information and Responses After Testing
NCT01992471
Biomarkers in Predicting Response to Tamoxifen and Letrozole in Postmenopausal Women With Primary Breast Cancer Treated on Clinical Trial CAN-NCIC-MA17
NCT00897065
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Participants with BIRADS 0-5
Men and woman 18 years and older who are participants with BIRADS 0-5 who present to breast radiology for biopsy or any new breast patient.
Biospecimen Collection
Blood collection at baseline and time of surgery
Surgical Tissue Collection
Tissue collection will be attempted at time of surgery
Survey Collection
Survey collection at baseline, post-surgery, at 1, 3 and 5 year follow up visits
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Biospecimen Collection
Blood collection at baseline and time of surgery
Surgical Tissue Collection
Tissue collection will be attempted at time of surgery
Survey Collection
Survey collection at baseline, post-surgery, at 1, 3 and 5 year follow up visits
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Any new breast patient seen at UM/SCCC or JHS will be invited to participate in the study.
* Men and women 18 years of age and older are eligible to participate in the study.
Exclusion Criteria
* Patients unable to complete the survey.
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Memorial Sloan Kettering Cancer Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Neha Goel, MD, MPH
Role: PRINCIPAL_INVESTIGATOR
Memorial Sloan Kettering Cancer Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of California, Los Angeles (Specimen Analysis only)
Los Angeles, California, United States
University of Miami (Data Collection Only)
Miami, Florida, United States
Memorial Sloan Kettering Cancer Center (All protocol activites)
New York, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Steven Cole, PhD
Role: primary
Neha Goel, MD, MPH
Role: primary
Related Links
Access external resources that provide additional context or updates about the study.
Memorial Sloan Kettering Cancer Center
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
24-372
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.